Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Nov;62(5):736–741. doi: 10.1038/bjc.1990.369

Biochemical and pharmacological consequences of the interaction between methotrexate and ketoprofen in the rabbit.

A Perrin 1, G Milano 1, A Thyss 1, P Cambon 1, M Schneider 1
PMCID: PMC1971536  PMID: 2245165

Abstract

Severe methotrexate (MTX) toxicity is a proven complication of associations of MTX and non-steroidal anti-inflammatory drugs (NSAIDs). This study investigated the interaction between MTX (50 or 100 mg kg-1) and ketoprofen (KP) (3 mg kg-1 day-1, pretreatment for 8 days) in the rabbit. The drug association induced a reversible increase in blood urea and creatinine. The severity degree of renal dysfunction was significantly related to the MTX dose; it was not modified by prolonged exposure to KP after MTX administration. The biological markers of haematopoietic and hepatic functions were unchanged. Pretreatment by KP induced a marked reduction (70%) in the urinary excretion of the prostaglandin 6-keto-PGF1 alpha. MTX dose-related alterations in MTX pharmacokinetics were also observed with the drug association: at a MTX dose of 100 mg kg-1, the presence of KP significantly reduced the total body clearance, the renal clearance and the fraction of MTX eliminated in urine as compared to controls. An appreciable reduction in the plasma binding of MTX was also noted in vivo when KP was associated. This experimental study confirms the existence of an interaction between MTX and KP and demonstrates its renal origin.

Full text

PDF
736

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. H., Howie A. J., Michael J., McConkey B., Bacon P. A., Adu D. Non-steroidal anti-inflammatory drugs and renal failure. Lancet. 1986 Jan 11;1(8472):57–60. doi: 10.1016/s0140-6736(86)90714-2. [DOI] [PubMed] [Google Scholar]
  2. Ahern M., Booth J., Loxton A., McCarthy P., Meffin P., Kevat S. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs? J Rheumatol. 1988 Sep;15(9):1356–1360. [PubMed] [Google Scholar]
  3. Budman D. R., Schulman P., Vinciguerra V., Degnan T. J. Phase I trial of spirogermanium given by infusion in a multiple-dose schedule. Cancer Treat Rep. 1982 Jan;66(1):173–175. [PubMed] [Google Scholar]
  4. Carmichael J., Shankel S. W. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med. 1985 Jun;78(6 Pt 1):992–1000. doi: 10.1016/0002-9343(85)90223-2. [DOI] [PubMed] [Google Scholar]
  5. Collier C. P., MacLeod S. M., Soldin S. J. Analysis of methotrexate and 7-hydroxymethotrexate by high-performance liquid chromatography and preliminary clinical studies. Ther Drug Monit. 1982;4(4):371–380. doi: 10.1097/00007691-198212000-00007. [DOI] [PubMed] [Google Scholar]
  6. Daly H., Boyle J., Roberts C., Scott G. Interaction between methotrexate and non-steroidal anti-inflammatory drugs. Lancet. 1986 Mar 8;1(8480):557–557. doi: 10.1016/s0140-6736(86)90910-4. [DOI] [PubMed] [Google Scholar]
  7. Dunn M. The role of arachidonic acid metabolites in renal homeostasis. Non-steroidal anti-inflammatory drugs renal function and biochemical, histological and clinical effects and drug interactions. Drugs. 1987;33 (Suppl 1):56–66. doi: 10.2165/00003495-198700331-00009. [DOI] [PubMed] [Google Scholar]
  8. Fabre I., Fabre G., Cano J. P. 7-Hydroxymethotrexate cytotoxicity and selectivity in a human Burkitt's lymphoma cell line versus human granulocytic progenitor cells: rescue by folinic acid and nucleosides. Eur J Cancer Clin Oncol. 1986 Oct;22(10):1247–1254. doi: 10.1016/0277-5379(86)90327-5. [DOI] [PubMed] [Google Scholar]
  9. Huang K. C., Wenczak B. A., Liu Y. K. Renal tubular transport of methotrexate in the rhesus monkey and dog. Cancer Res. 1979 Dec;39(12):4843–4848. [PubMed] [Google Scholar]
  10. Jacobs S. A., Stoller R. G., Chabner B. A., Johns D. G. 7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate. J Clin Invest. 1976 Feb;57(2):534–538. doi: 10.1172/JCI108308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kantor T. G. Ketoprofen: a review of its pharmacologic and clinical properties. Pharmacotherapy. 1986 May-Jun;6(3):93–103. doi: 10.1002/j.1875-9114.1986.tb03459.x. [DOI] [PubMed] [Google Scholar]
  12. Lopez C., Bourdeaux M., Chauvet M., Gilli R., Briand C. Binding of 7-hydroxy-methotrexate to human serum albumin. Biochem Pharmacol. 1986 Aug 15;35(16):2834–2836. doi: 10.1016/0006-2952(86)90199-1. [DOI] [PubMed] [Google Scholar]
  13. Maiche A. G. Acute renal failure due to concomitant action of methotrexate and indomethacin. Lancet. 1986 Jun 14;1(8494):1390–1390. doi: 10.1016/s0140-6736(86)91706-x. [DOI] [PubMed] [Google Scholar]
  14. Nierenberg D. W. Competitive inhibition of methotrexate accumulation in rabbit kidney slices by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 1983 Jul;226(1):1–6. [PubMed] [Google Scholar]
  15. Patrono C., Pugliese F., Ciabattoni G., Patrignani P., Maseri A., Chierchia S., Peskar B. A., Cinotti G. A., Simonetti B. M., Pierucci A. Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest. 1982 Jan;69(1):231–239. doi: 10.1172/JCI110435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Paxton J. W. Protein binding of methotrexate in sera from normal human beings: effect of drug concentration, pH, temperature, and storage. J Pharmacol Methods. 1981 May;5(3):203–213. doi: 10.1016/0160-5402(81)90088-7. [DOI] [PubMed] [Google Scholar]
  17. Populaire P., Terlain B., Pascal S., Decouvelaere B., Renard A., Thomas J. P. Comportement biologique: taux sériques, excrétion et biotransformation de l'acide (benzoyl-3 phényl)-2 propionique ou kétoprofène chez l'animal et chez l'homme. Ann Pharm Fr. 1973 Dec;31(12):735–749. [PubMed] [Google Scholar]
  18. Powell W. S. Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol. 1982;86:467–477. doi: 10.1016/0076-6879(82)86218-6. [DOI] [PubMed] [Google Scholar]
  19. Sasaki K., Hosoya R., Wang Y. M., Raulston G. L. Formation and disposition of 7-hydroxymethotrexate in rabbits. Biochem Pharmacol. 1983 Feb 1;32(3):503–507. doi: 10.1016/0006-2952(83)90530-0. [DOI] [PubMed] [Google Scholar]
  20. Schlondorff D., Ardaillou R. Prostaglandins and other arachidonic acid metabolites in the kidney. Kidney Int. 1986 Jan;29(1):108–119. doi: 10.1038/ki.1986.13. [DOI] [PubMed] [Google Scholar]
  21. Seither R. L., Rape T. J., Goldman I. D. Further studies on the pharmacologic effects of the 7-hydroxy catabolite of methotrexate in the L1210 murine leukemia cell. Biochem Pharmacol. 1989 Mar 1;38(5):815–822. doi: 10.1016/0006-2952(89)90236-0. [DOI] [PubMed] [Google Scholar]
  22. Sennesael J., Van den Houte K., Verbeelen D. Reversible membranous glomerulonephritis associated with ketoprofen. Clin Nephrol. 1986 Oct;26(4):213–215. [PubMed] [Google Scholar]
  23. Shen D. D., Azarnoff D. L. Clinical pharmacokinetics of methotrexate. Clin Pharmacokinet. 1978 Jan-Feb;3(1):1–13. doi: 10.2165/00003088-197803010-00001. [DOI] [PubMed] [Google Scholar]
  24. Singh R. R., Malaviya A. N., Pandey J. N., Guleria J. S. Fatal interaction between methotrexate and naproxen. Lancet. 1986 Jun 14;1(8494):1390–1390. doi: 10.1016/s0140-6736(86)91707-1. [DOI] [PubMed] [Google Scholar]
  25. Thyss A., Milano G., Kubar J., Namer M., Schneider M. Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet. 1986 Feb 1;1(8475):256–258. doi: 10.1016/s0140-6736(86)90786-5. [DOI] [PubMed] [Google Scholar]
  26. Verbeeck R. K., Blackburn J. L., Loewen G. R. Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet. 1983 Jul-Aug;8(4):297–331. doi: 10.2165/00003088-198308040-00003. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES